Cargando…
Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study
BACKGROUND: The development of systemic chemotherapy including immune checkpoint inhibitors (ICIs) has provided patients with unresectable advanced non-small cell lung cancer (NSCLC) an opportunity to undergo surgical intervention after initial treatment. However, no consensus regarding the indicati...
Autores principales: | Higuchi, Mitsunori, Inomata, Sho, Yamaguchi, Hikaru, Saito, Takuro, Suzuki, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360220/ https://www.ncbi.nlm.nih.gov/pubmed/37475037 http://dx.doi.org/10.1186/s13019-023-02310-5 |
Ejemplares similares
-
Pathological Complete Response after Immune-Checkpoint Inhibitor Followed by Salvage Surgery for Clinical Stage IV Pulmonary Adenocarcinoma with Continuous Low Neutrophil-to-Lymphocyte Ratio: A Case Report
por: Higuchi, Mitsunori, et al.
Publicado: (2021) -
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021) -
Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
por: Muto, Satoshi, et al.
Publicado: (2023) -
Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy
por: Li, Kuo, et al.
Publicado: (2021) -
Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
por: Nawashiro, Ayako, et al.
Publicado: (2022)